medical device regulatory timelines

Regulatory review timelines for medical devices in 2026 remain a critical determinant of commercialization strategy in the United States. Device manufacturers must navigate a structured but evolving framework governed by the Food and Drug Administration, where review speed is influenced by device classification, submission pathway, and data quality. As innovation accelerates across digital health, diagnostics, … Read more